CAMBRIDGE, MA / ACCESS Newswire / May 12, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked no. 1 on TIME's 2026 list of the World's Most Impactful Companies. The recognition highlights ...

He’s a great doctor, and he was having some difficulty,' Trump told reporters outside the White House. 'But he’s going to go ...

The Street-high price target of $38 suggests it could nearly triple from here over the next 12 months. 3M stock also emerges ...

Stock surge explained: Moderna’s shares rose nearly 6% after reporting strong immune responses and safety in early hantavirus vaccine trials. Cruise outbreak toll: An Andes virus outbreak aboard MV ...

Cruise ship outbreak: Three deaths and multiple cases of the Andes strain have been linked to the MV Hondius cruise ship, prompting global health monitoring. Moderna's research role: The company has ...

The hantavirus outbreak on the MV Hondius poses an ‘extremely low’ overall risk to the public, health officials said ...

After facing pressure from the summer of 2021 through the end of 2025, Moderna shares have staged an impressive comeback, ...

Moderna stock rose 8% in premarket on Monday, extending its 12% rally on Friday. What’s behind the move: The biotech is researching vaccines to protect against ha ...

The company has been quietly researching hantaviruses for years, and that work is gaining new relevance. Moderna has been studying hantaviruses with the U.S. Army in pre-clinical work and began a ...

Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are up roughly 6% in Monday morning trading, changing hands near ...

Buy MRNA. The stock is being repriced for “outbreak optionality” after confirmation of early hantavirus vaccine/treatment work. Even if revenue is small, the market is paying for speed and platform ...